Apocynin-tandospirone derivatives demonstrate antioxidant properties in the animal model of schizophrenia
Authors:
- Takashi UeharaTUTakashi Uehara
- Masayoshi KurachiMKMasayoshi Kurachi
- Takashi KondoTKTakashi Kondo
- Hitoshi AbeHAHitoshi Abe
- Qing-Li ZhaoQZQing-Li Zhao
- Hiroko ItohHIHiroko Itoh
- Tomiki SumiyoshiTSTomiki Sumiyoshi
- Michio SuzukiMSMichio Suzuki
Open Access
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Advances in Redox Research
- Vol. 3
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (21K07511)
- Japan Society for the Promotion of Science (20H03610)
- National Center of Neurology and Psychiatry (3-1)
- National Center of Neurology and Psychiatry (2020-B-08)
- Japan Agency for Medical Research and Development (21he2202007)
- Japan Agency for Medical Research and Development (20dk0307099)
This publication has 74 references indexed in Scilit:
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysisThe Lancet, 2009
- Possible dose–side effect relationship of antipsychotic drugs: relevance to cognitive function in schizophreniaExpert Review of Clinical Pharmacology, 2008
- In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems2008
- Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in SchizophreniaArchives of General Psychiatry, 2006
- Effectiveness of Antipsychotic Drugs in Patients with Chronic SchizophreniaNew England Journal of Medicine, 2005
- Predictive Values of Neurocognition and Negative Symptoms on Functional Outcome in Schizophrenia: A Longitudinal First-Episode Study With 7-Year Follow-UpAmerican Journal of Psychiatry, 2005
- Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICSSchizophrenia Research, 2004
- Catching Up on SchizophreniaNeuron, 2000
- Epidemiology and natural history of schizophreniaBiological Psychiatry, 1999
- The Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in SchizophreniaSchizophrenia Bulletin, 1999